Royal Bank of Canada’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45K | Buy |
40,728
+38,417
| +1,662% | +$42.4K | ﹤0.01% | 5598 |
|
|
2025
Q1 | $2K | Sell |
2,311
-17,738
| -88% | -$15.4K | ﹤0.01% | 6183 |
|
|
2024
Q4 | $123K | Sell |
20,049
-22,029
| -52% | -$135K | ﹤0.01% | 4749 |
|
|
2024
Q3 | $696K | Buy |
42,078
+19,738
| +88% | +$326K | ﹤0.01% | 3435 |
|
|
2024
Q2 | $154K | Buy |
22,340
+22,038
| +7,297% | +$152K | ﹤0.01% | 4587 |
|
|
2024
Q1 | $3K | Sell |
302
-5,411
| -95% | -$53.8K | ﹤0.01% | 6143 |
|
|
2023
Q4 | $48K | Sell |
5,713
-490
| -8% | -$4.12K | ﹤0.01% | 5476 |
|
|
2023
Q3 | $52K | Buy |
6,203
+758
| +14% | +$6.35K | ﹤0.01% | 5275 |
|
|
2023
Q2 | $50K | Buy |
5,445
+553
| +11% | +$5.08K | ﹤0.01% | 5333 |
|
|
2023
Q1 | $67K | Sell |
4,892
-503
| -9% | -$6.89K | ﹤0.01% | 5082 |
|
|
2022
Q4 | $91K | Buy |
5,395
+1,066
| +25% | +$18K | ﹤0.01% | 5055 |
|
|
2022
Q3 | $99K | Buy |
4,329
+2,272
| +110% | +$52K | ﹤0.01% | 4825 |
|
|
2022
Q2 | $37K | Sell |
2,057
-446
| -18% | -$8.02K | ﹤0.01% | 5388 |
|
|
2022
Q1 | $66K | Sell |
2,503
-1,148
| -31% | -$30.3K | ﹤0.01% | 5432 |
|
|
2021
Q4 | $107K | Sell |
3,651
-25,093
| -87% | -$735K | ﹤0.01% | 5355 |
|
|
2021
Q3 | $1.89M | Buy |
28,744
+123
| +0.4% | +$8.09K | ﹤0.01% | 2717 |
|
|
2021
Q2 | $2.38M | Buy |
28,621
+5,392
| +23% | +$449K | ﹤0.01% | 2566 |
|
|
2021
Q1 | $1.78M | Buy |
23,229
+21,214
| +1,053% | +$1.63M | ﹤0.01% | 2720 |
|
|
2020
Q4 | $178K | Buy |
2,015
+3
| +0.1% | +$265 | ﹤0.01% | 4412 |
|
|
2020
Q3 | $149K | Hold |
2,012
| – | – | ﹤0.01% | 4266 |
|
|
2020
Q2 | $147K | Sell |
2,012
-367
| -15% | -$26.8K | ﹤0.01% | 4168 |
|
|
2020
Q1 | $133K | Buy |
2,379
+43
| +2% | +$2.4K | ﹤0.01% | 4117 |
|
|
2019
Q4 | $89K | Buy |
+2,336
| New | +$89K | ﹤0.01% | 4564 |
|